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Purpose: High central blood pressure is more predictive of cardiovascular disease (CVD) versus high pe-
ripheral blood pressure. Measures of central pressures (CPs) include, central systolic blood pressure (CSBP)
and central diastolic blood pressure. Measures of central pressures augmentation (CPsA) include
augmentation pressure (AP) and the augmentation index @ 75 beats$min1 (AIx@75). Increased sym-
pathetic tone (ST) is also associated with CVD. The low to high frequency ratio (LF/HF) is often used to
determine sympatho-vagal balance. Given the association between ST, CPs, CPsA and CVD there is a need
to understand the association between these predictors of CVD. The aims of this study were to examine the
association between the LF/HF ratio, CPs, and CPsA in men and women collectively and based on gender.
Methods: We measured the LF/HF ratio, CSBP, AP, and AIx@75 in 102 participants (41F/61M). The LF/
HF ratio was determined via power spectral density analysis. CSBP, AP, and AIx@75 were determined via
applanation tonometry. Results: The LF/HF ratio was inversely associated with AP (r5 –0.26) and AIx @75pCorresponding author. Southern Connecticut State University, 501 Crescent Street, New Haven, CT 06515,
USA. Tel.: þ1 (203) 392 6081; Fax: þ1 (203) 392 6093, E-mail: Latchmanp1@southernct.edu
156 Physiology International 107 (2020) 1, 155–165(r 5 –0.29) in the combined group of men and women. The LF/HF ratio was inversely associated with
CSBP (r5 –0.27), AP (r5 –0.28), and AIx@75 (r5 –0.32) in men, but not in women. Conclusion: There is
an inverse association between the LF/HF ratio, AP, and AIx@75 in men and women combined. The
association between the LF/HF ratio, CSBP, AP, and AIx@75, differs based on gender.
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augmentation indexINTRODUCTION
Cardiovascular disease (CVD) is still a main cause of health loss worldwide [32]. Although high
peripheral blood pressure (PBP) increases the risk for CVD [30], research suggests that irre-
spective of patients having similar PBP, those with higher central blood pressure (CBP) were at
increased risk for CVD versus those with low CBP [29, 31, 38], suggesting CBP to be an in-
dependent predictor of CVD [2, 29, 31, 36, 38]. In addition to elevated CBP, increased activity
from the sympathetic nervous system is also associated with many negative cardiovascular
outcomes [21].
In this paper, central pressures (CPs) will be indicative of central systolic blood pressure
(CSBP) and central diastolic blood pressure (CDBP). Central pressures augmentation (CPsA)
will be indicative of augmentation pressure (AP) and the augmentation index (AIx). As related
to CPs, past works have found CSBP to be highly predictive of cardiovascular events [29, 35];
this relationship could be due in part to the concomitant increase in work by the myocardium
imposed by an increase in CSBP. From a CDBP perspective, an attenuation in CDBP caused by
the early return of reflective waves can promote reduced coronary perfusion leading to reduced
blood flow to the myocardium [12].
CPsA is expressed in absolute terms as the AP or as a percentage of pulse pressure expressed
as the AIx. AP has been demonstrated to be predictive of negative cardiovascular health and the
AIx has been shown to be predictive for the presence of coronary artery disease (CAD) [13, 16,
36], adverse cardiovascular events in patients with established CAD [8], and negative outcomes
associated with end-stage renal disease [20].
The sympathetic branch of the autonomic nervous system is involved in many aspects of
cardiovascular physiology, including its direct role in myocardial activity, vasomotor tone and
its role in the renin-angiotensin-aldosterone system. Increased sympathetic tone (ST) is
implicated in impaired cardiovascular functioning and is associated with heart failure [39],
arrhythmias [21] and increased PBP [11]. Both the sympathetic and parasympathetic branch of
the autonomic nervous system promotes changes in the variability of the R-R intervals between
heart beats which is referred to as heart rate variability (HRV) [27]. HRV is therefore repre-
sentative of the variation in time between R-R intervals. In the frequency domain the high
frequency (HF) band is believed to be representative of parasympathetic modulation while the
low frequency (LF) band is considered to be representative of both sympathetic and para-
sympathetic modulation with a dominance of sympathetic modulation [14]. The LF–HF ratio
(LF/HF) is considered to be indicative of sympatho-vagal balance [25, 26]. Thus, an increase in
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parasympathetic. Although the use of the LF/HF ratio in assessing sympatho-vagal balance has
been questioned [3], the LF/HF ratio has been used in numerous studies [15, 23, 34] and
represents an easy, non-invasive, inexpensive way of measuring sympatho-vagal balance in
young individuals, the elderly [23], pediatric [34] and certain clinical populations [15]. Due to
the non-invasive nature of the LF/HF ratio measurement it is ideally suited for determining
sympatho-vagal balance in a wider population range versus other more invasive methods of
assessing ST.
The association between ST and PBP has been extensively studied, however, despite the
understanding that CPs and CPsA are robust predictors of cardiovascular health and given the
role of elevated ST in CVD, there is a surprising paucity of research examining the association
between ST, CPs, and CPsA. One prior study examined the association between muscle sym-
pathetic nerve activity (MSNA) and aortic wave reflections and suggested that in a healthy group
of young men and women, MSNA was not associated with CPs, AP or AIx. However, when this
group was divided by gender, MSNA was positively associated with AP and AIx in men but was
inversely associated in women [4]. Although MSNA is a robust indicator of ST, this measure-
ment requires great technical skill and involves the insertion of a tungsten microelectrode into
the peroneal nerve. These characteristics reduce the suitability of MSNA as the method of
assessing ST in many populations, including: children, the elderly, and certain clinical pop-
ulations. Therefore, there is a need to be able to examine the association between ST and
measures of CPs and CPsA using methods that are more suitable for a wider population range.
Given the associations between ST, CPs, CPsA, and CVD, there is a great need to not only
understand the association between these predictors of CVD and CVD itself, but also for an
understanding of the association between these predictors of CVD using a non-invasive method
of ST assessment that is suited to a wider population range. An understanding of the associa-
tions between ST, CPs, and CPsA could allow for an advancement in the physiological
knowledge regarding the etiology and treatment of CVD.
Therefore, the primary aim of the current study was to examine the association between the
LF/HF ratio, CPs, and CPsA in a group of young men and women. Additionally, based on our
previous findings that the association between the Alx and autonomic modulation differ based
on gender [19], and on other findings demonstrating differences in the regulation of PBP based
on gender [11] the secondary aim was to examine the association between the LF/HF ratio, CPs,
and CPsA based on gender. We hypothesized that there will be no association between the LF/
HF ratio, CPs and CPsA in young men and women combined but that these association will
differ based on gender.METHODS
Participants included 102 young men and women (M 5 61; W 5 41) recruited from the
Southern Connecticut State University student population and the New Haven area. Inclusion
criteria included no clinical indication of cardiovascular or metabolic disease, non-smoker,
medication-free and possessing normal electrocardiogram (ECG) and blood pressure (BP)
patterns. This research complied with the Helsinki Declaration and was approved by the
Institutional Review Board (IRB) at Southern Connecticut State University. Each participant
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between 7:00 and 10:00 a.m., prior to arrival they were advised not to exercise or consume food
for 48 and 12 hours, respectively, prior to testing but were allowed to drink water. Anthropo-
metric measurements were taken followed by two to three BP measurements after 5 min of
seated rest. After anthropometric measurements were taken CPs and CPsA measurements were
taken followed by measurement of the LF/HF ratio.
Measurement of the CPs, CPsA and LF/HF ratio
CSBP, CDBP, AP and AIx. The SphygmoCor system (AtCor Medical Pty Ltd, West Ryde,
Australia) used pulse wave analysis to determine CSBP, CDBP, AP, and AIx [24]. A high-fidelity
transducer applanation tonometer was placed over the left radial pulse. The system then
analyzed the radial waveform via a generalized transfer function that was validated intra-arte-
rially [7, 28] to determine CSBP, CDBP, AP, and AIx.
AP was established as the amplitude of the reflected wave and was defined as the difference
between the initial and second systolic shoulders of the aortic systolic blood pressure [38]. AIx
was established as AP divided by pulse pressure expressed as a percent of the central pulse
pressure [38]. Since heart rate has an effect on AIx [24, 37], AIx values were adjusted to be a
standard heart rate of 75 beats$min1, denoted as AIx@75. Measurements were taken from the
left radial pulse after 6 min of rest in a seated position. The SphygmoCor system has built in
quality control parameters. These parameters are used to determine validity and reproducibility
of a waveform. An operator index of ≥85 represents the highest level of validity and repro-
ducibility of a waveform. All pressure data collected in this study conformed to an operator’s
index of ≥85.
The LF/HF ratio. For the LF/HF ratio measurement, participants were instrumented with a
Nexfin monitor (BMEYE, Netherlands), which used ECG to determine continuous R-R interval
measurements. The R-R interval measurement was taken for 8 min in a seated position but only
the final 5 min of data were used in the analysis. In the current study only the frequency–
domain method was used to assess HRV. Here, power spectral density analysis of HRV was used
to determine autonomic modulation; with a priori power spectra of the R-R interval within the
0.15–0.4 Hz bandwidth indicating primarily parasympathetic modulation; defining the HF
segment of HRV, referred to as high frequency of R-R interval denoted HFR-R. The LF segment
of HRV was located within the 0.04–0.15 Hz bandwidth denoted as LFR-R and is considered to
represent a mixture of sympathetic and parasympathetic modulation [14]. Sympatho-vagal
balance was determined as the ratio between the LF and HF spectra of HRV and is denoted as
LF/HF [25]. Participants were instructed to breathe at 12 breaths$min1 (0.2 Hz), guided by a
light moving up and down on a computer screen. This breathing protocol avoided the effect of a
varied respiratory rate on spectral distributions [9]. The absolute value of the LF and HF
components were log transformed to remove skewness and minimize the large SD customarily
present in these data and were indicated as lnLF and lnHF respectively. Women were tested
within 5 days of the cessation of menstruation.
Statistical analysis. Means and standard errors are presented for the demographic variables of
age (years), height (centimeters), body mass (kilograms) and body mass index (kg$m2). Means
and standard errors are also presented for the LF/HF ratio, CSBP (mmHg), CDBP (mmHg), AP
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differences in the aforementioned variables exist by gender. To determine the associations be-
tween LF/HF, CPs, and CPsA values, Pearson's correlation coefficients and linear regression
analyses were performed. Significance was set at P < 0.05 for all statistics and analyses were
obtained using SPSS for Windows, Version 23 (IBM Corporation 2015, Armonk, NY).RESULTS
Participant demographics are presented in Table 1. ST, and measures of CPs and CPsA are
presented in Table 2. Independent t-test revealed no significant difference in age based on
gender, however men demonstrated greater height, body mass and BMI versus women (Table 1,
P < 0.05). No significant differences were found in lnLF and lnHF between men and women
(Table 2). There was no significant difference in the LF/HF ratio between men and women
(Table 2). Men demonstrated greater CSBP and CDBP versus women (Table 2, P < 0.05).
Women demonstrated greater AP and AIx@75 versus men (Table 2, P < 0.05).Table 1. Demographic variables for men (n 5 61) and women (n 5 41)
Men Women P value
Age (y) 21.5 ± 0.4 22.1 ± 0.4 0.39
Height (cm) 175.7 ± 0.8 164.8 ± 1.0 <0.001**
Body mass (kg) 77.3 ± 1.3 64.2 ± 1.7 <0.001**
BMI (kg$m2) 25.0 ± 0.3 23.6 ± 0.5 0.035*
BMI: body mass index. Data are in means ± SEM.
*P 5 <0.05.
**P 5 <0.001.
Table 2. Sympathetic tone and blood pressure parameters in men (n 5 61) and women (n 5 41)
Men Women P value
CSBP (mm Hg) 96.5 ± 0.9 92.2 ± 0.9 <0.001**
CDBP (mm Hg) 67.9 ± 0.8 64.4 ± 0.7 0.001*
AP (mm Hg) 2.2 ± 0.4 3.7 ± 0.5 0.034*
AIx@75 beats$min–1 (%) 1.4 ± 1.3 9.9 ± 1.4 <0.001**
lnHF (ms2) 7.3 ± 0.1 7.1 ± 0.1 0.357
lnLF (ms2) 7.0 ± 0.1 6.8 ± 0.1 0.167
HFnu 56.1 ± 2.6 56.6 ± 2.8 0.900
LFnu 43.2 ± 2.6 43.0 ± 2.7 0.957
LF/HF 1.1 ± 0.1 0.9 ± 0.1 0.406
CSBP: central systolic blood pressure; CDBP: central diastolic blood pressure; AP: augmentation pressure;
AIx@75 beatsmin1, augmentation index at 75 beats$min–1; lnHF: log transform high frequency; lnLF: log
transform low frequency; HFnu: normalized high frequency; LFnu: normalized low frequency; LF/HF: low-
high frequency ratio. Data are in means ± SEM.
*P 5 <0.05.
**P 5 <0.001.























Men –0.27* 0.032 –0.14 0.265 –0.28* 0.027 –0.32* 0.012
Women –0.05 0.744 0.08 0.604 –0.21 0.180 –0.21 0.169
All –0.18 0.068 –0.06 0.544 –0.26** 0.007 –0.29** 0.003
ST: sympathetic tone; CSBP: central systolic blood pressure; CDBP: central diastolic blood pressure; AP:
augmentation pressure; AIx@75 beats$min1: augmentation index at 75 beats$min–1.
*P 5 <0.05.
**P 5 <0.01.
Figure 1. Association between the LF/HF ratio and CSBP in men and women
Figure 2. Association between the LF/HF ratio and AIx@75 in men and women
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inversely associated with AP (r 5 –0.26; P 5 < 0.01) and AIx @75 (r 5 –0.29; P 5 < 0.01) but
not with CSBP or CDBP (Table 3).
In men the LF/HF ratio was inversely associated with CSBP (r 5 –0.27; P 5 0.03), (Fig. 1),
AP (r 5 –0.28; P 5 0.02), (Table 3) and AIx@75 (r 5 –0.32; P 5 0.01), (Fig. 2) but not CDBP
(Table 3). In women there were no associations between the LF/HF ratio, CSBP (r 5 –0.05; P 5
0.74), (Fig. 1), CDBP (r 5 0.08; P 5 0.60), AP (r 5 –0.21; P 5 0.18), (Table 3), or AIx@75 (r 5
–0.21; P 5 0.16), (Fig. 2).DISCUSSION
The main finding of this study was that the association between the LF/HF ratio, CSBP, AP, and
AIx@75, differed based on gender. Here, the new finding was that the LF/HF ratio was inversely
associated with, CSBP, AP, and AIx@75, in young men but not in young women. This finding
was in keeping with our hypothesis. Additionally, the LF/HF ratio was found to be inversely
associated with AP and AIx@75 in a group of young men and women. However, this finding
differed from our hypothesis that there would be no association between the LF/HF ratio, CPs
and CPA in a group of young men and women.
We did not expect an inverse association between the LF/HF ratio, CSBP, AP and AIx@75 in
men. Here, these associations suggest that as the LF/HF ratio increases, there is a concomitant
attenuation in CSBP and CPA. This observation suggests that as the sympatho-vagal balance
moved towards sympathetic dominance there was a concomitant attenuation in wave reflection.
While this finding was not expected, the concept of increased ST associated with an attenuation
in measures of CPsA is not completely new, as one previous study demonstrated this association
in women using MSNA [4]. The reason for the inverse association between the LF/HF ratio,
CSBP, AP, and AIx@75 in young men cannot be explained by this study; however, one could
speculate that a shift towards sympathetic dominance over the parasympathetic modulation
could result in an increased heart rate. Decreased heart rate is associated with an increase in the
ventricular ejection period which gives rise to summation of the incident and reflective wave
[24], which could cause an increase in CPsA. Conversely, an increase in heart rate, which could
result from an increase in the LF/HF ratio, could result in a decrease of the ventricular filling
period and decrease summation of the incident and reflective wave, which could in part help to
promote the inverse association between the LF/HF ratio, CSBP, AP, and AIx@75. While the
above would seem like a plausible speculation, the inverse association was observed even when
the heart rate was held constant at 75 beats$min1, suggesting increased heart rate was unlikely
responsible for the inverse association between the LF/HF ratio, CSBP, AP, and AIx@ 75.
One prior study using MSNA found a positive association between MSNA, AP, and AIx in
young men [4]. The differences in the nature of the association between MSNA, CPs, and CPsA
observed in that prior study and the association between the LF/HF ratio, CPs, and CPsA
observed in the current study could perhaps be associated in some way to the understanding that
MSNA is derived from direct vasoconstrictor ST to the vasculature of skeletal muscle [18], while
the LF/HF ratio is obtained from sympatho-vagal balance derived from the heart, along with the
understanding that ST directed towards different components of the BP equation could have
different impacts on BP. Research suggests that MSNA was inversely associated with the cardiac
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resistance (TPR) in young men [6]. Additionally, the association between MSNA and the
different components of the BP equation has been demonstrated not to be fixed in all people.
Since ST as determined by MSNA has been found to be associated in a different manner with
various components of the BP equation, and since ST influence on the BP equation differs
between individuals, if the LF/HF ratio for any reason was to be more associated with the
reduced CO component versus the TPR component, then perhaps it could be speculated that the
association between the LF/HF ratio, CSBP, AP and AIx@75 could be inverse in nature.
While we observed an inverse association between the LF/HF ratio, CSBP, AP, and AIx@75
in young men, we found no association in young women. Explaining the lack of association
between the above variables is beyond the scope of this study. The finding of differences between
the association of the LF/HF ratio, CSBP, AP, and AIx@75 based on gender was not surprising,
since gender related differences in the association between MSNA and measures of CPs and
CPsA have been previously reported [4]. One probable reason for the lack of association be-
tween the LF/HF ratio, CSBP, AP, and AIx@75 in women could be that estrogen stimulates
endothelial nitric oxide (NO) synthase (eNOS), which would result in an increase in endothelial
NO availability [22]. Briefly, NO will stimulate soluble guanylyl cyclase, which will promote the
formation of cyclic guanosine monophosphate (cGMP). cGMP would then activate protein
kinase G (PKG), which would result in the movement of intracellular calcium (Ca) into the
sarcoplasmic reticulum, the movement of Ca out of the cell and the opening of potassium
channels leading to hyperpolarization. With a decreased intracellular Ca level, there would be a
concomitant inactivation of calmodulin. Here, myosin light chain kinase (MLCK) would not be
activated and would therefore not be able to phosphorylate myosin, which would lead to smooth
muscle relaxation [40]. Here, plasma estrogen in women could serve to restrain ST to the
vasculature resulting in vasodilation. This vasodilation could lead to an attenuation in wave
reflection and could provide a basis for the observation of no association between the LF/HF
ratio, CSBP, AP, and AIx@75 seen in young women in the current study.
Women were found to have significantly higher AIx@75 versus men, which corroborated
with prior work [4]. This greater AIx@75 can perhaps be explained in part by women being
significantly shorter than men. Being shorter is suggestive of smaller aortas, and here the
reflective sites would be closer to the heart and therefore result in earlier wave reflections [33].
We found no association between the LF/HF ratio and CDBP in men and women combined
or based on gender. The mean central systolic and diastolic blood pressure values in the current
study pointed toward the lower end of the central blood pressure spectrums. However, the
operator index for the systolic and diastolic pressure values collected during this study con-
formed to an operator index of ≥85, which represents the highest values for validity and
reproducibility of the data collected. Additionally, we observed other studies with similar central
pressure values [1, 5]. Although inter- and intra-individual variability of HRV parameters is
known, our HRV parameters were corroborated by a prior study [17].
To the best of our knowledge, this is the first study to examine the association between the
LF/HF ratio, CPs, and CPsA. Our finding that these associations differ based on gender is
corroborated by a prior study which used MSNA as an indicator of ST, however, the nature of
the associations was different between these studies. The findings from the current study are not
suggesting that ST is not associated with CVD, as increased ST has been found to be associated
with hypertension, congestive heart failure, and myocardial infarction [10]. Importantly,
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vascular information for men versus women. Additionally, these findings suggest that the as-
sociation between ST, CPs and CPsA differs based on the method used to assess ST. Findings
from the current study, could serve to underscore the complex nature of the association between
ST and measures of CPs and CPsA.LIMITATION OF THE STUDY
This study was limited since body weight was not accounted for when determining the fre-
quency domain parameters.
To summarize, in young men and women, the LF/HF ratio was inversely associated with AP
and AIx@75; however, these associations were gender specific, with the LF/HF ratio in men
being inversely associated with CSBP, AP, and AIx@75 with no association found in women.
These findings represent the first observations of the association between the LF/HF ratio and
measures of CPs and CPsA. The authors hope that the nature of these findings will underscore
the need for further research examining these associations.
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